|Study Type:||Phase I|
|Stage:||Primary analysis complete|
|Study Start Date:||NA|
|Study Made Public:||NA|
A Phase I open-label trial to evaluate the safety and immunogenicity of an HIV-1 subtype C gp140 vaccine with MF59 adjuvant in healthy, HIV-1 uninfected adult participants previously primed or unprimed with HIV-1 subtype B envelope subunit vaccines with MF59
HVTN 088 is a Phase I clinical trial to evaluate the safety and immunogenicity of HIV-1 subtype C gp140 with MF59.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.